iQIYI Partners with Digital Wallet Snaplii to Launch VIP Memberships in North America
iQIYI International VIP memberships will be available for purchase in the Snaplii app starting November 1 SINGAPORE, Nov. 9, 2025 /PRNewswire/ — iQIYI, a world-leading... Read more.
Summit urges joint efforts in shared digital future
BEIJING, Nov. 9, 2025 /PRNewswire/ — A news report from chinadaily.com.cn: Heightened efforts should be made to foster a vibrant and dynamic digital economy... Read more.
Biban Forum 2025 Concludes in Riyadh with Agreements Worth Over USD 10.1 Billion and Record Global Participation
RIYADH, Saudi Arabia, Nov. 9, 2025 /PRNewswire/ — The Small and Medium Enterprises General Authority (Monsha’at) has concluded Biban Forum 2025, Saudi... Read more.
Club Offers for Travel Enthusiasts in Canada
TORONTO, Nov. 9, 2025 /PRNewswire/ — Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces the release of new Club Offers for Club Members... Read more.
CGTN: How China’s high-standard opening up fuels high-quality development
BEIJING, Nov. 8, 2025 /PRNewswire/ — Following President Xi Jinping’s visits to Hainan and Guangdong, CGTN published an article on China’s strategic... Read more.
New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting
Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo in patients who had atopic dermatitis... Read more.
Zinzino AB (publ.): Zinzino acquires Mexican company Sanki to increase distribution capacity in North America and South America
GOTHENBURG, Sweden, Nov. 8, 2025 /PRNewswire/ — Zinzino has signed an agreement with Mexico-based direct sales company Sanki to acquire the rights to the company’s... Read more.
AMGEN’S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
Study Also Shows 36% Reduction in Risk of Heart Attack Repatha is the First and Only PCSK9 Inhibitor to Significantly Reduce the Risk of First Heart Attack and... Read more.
Vaughn College Hosts 11th Annual Manufacturing Day to Promote Career Opportunities and to Inspire the Next Generation of Engineering and Technology Professionals
The annual event hosted by Vaughn’s Engineering and Technology Department featuredpresentations from industry experts and STEM workshops for local community... Read more.
AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025
Pooled 48-week results from two Phase II studies show sustained antiviral responses and a favorable safety profile of AHB-137 in HBeAg-negative chronic hepatitis... Read more.